Clinical Trial Update: Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC [Phase 2]

View source ↗

Summary

Phase II trial evaluating concurrent nivolumab with external beam radiation therapy in advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Advanced Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED